<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Epilessia Idiopatica (Cane) - MedVet</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/howler/2.2.4/howler.min.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&family=Lexend:wght@400;600;700&display=swap" rel="stylesheet">
    <style>
        /* Stile base con palette VIOLA */
        body { font-family: 'Inter', sans-serif; background-color: #faf5ff; /* purple-50 */ color: #5b21b6; /* purple-800 */ }
        .content-section { background-color: #ffffff; border-radius: 0.75rem; box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -1px rgba(0, 0, 0, 0.06); }
        .nav-link { transition: all 0.2s; border-bottom: 2px solid transparent; color: #a855f7; /* purple-500 */ }
        .nav-link:hover, .nav-link.active { border-bottom-color: #9333ea; /* purple-600 */ color: #5b21b6; /* purple-800 */ }
        
        /* Modalit√† DSA (Accessibilit√†) */
        .dsa-mode {
            font-family: 'Lexend', sans-serif;
            background-color: #f8fafc !important; /* slate-50 */
            letter-spacing: 0.05em;
            line-height: 1.75;
            color: #1e293b; /* slate-800 */
        }
        .dsa-mode #main-header, .dsa-mode #main-footer { background-color: #000000 !important; }
        .dsa-mode #main-header h1, .dsa-mode #main-header a, .dsa-mode #main-footer p, .dsa-mode button { color: #ffffff !important; }
        .dsa-mode button { border: 1px solid #ffffff; }
        .dsa-mode .content-section { background-color: #ffffff; border: 1px solid #e2e8f0; }
        .dsa-mode h1, .dsa-mode h2, .dsa-mode h3, .dsa-mode p, .dsa-mode li { color: #1e293b; }
        .dsa-mode .prose strong { color: #000000; }
        .dsa-mode .prose h3 { color: #1e293b; border-bottom-color: #94a3b8; }
        .dsa-mode .prose h4 { color: #1e293b; }
        .dsa-mode .nav-link { color: #334155; } /* slate-700 */
        .dsa-mode .nav-link:hover, .dsa-mode .nav-link.active { border-bottom-color: #334155; color: #000000; }
        .dsa-mode .quiz-question { border-color: #cbd5e1; }
        .dsa-mode .quiz-option:hover { background-color: #f1f5f9; }

        /* Bottoni TTS */
        .tts-button { cursor: pointer; display: inline-block; margin-left: 10px; vertical-align: middle; color: #a78bfa; /* purple-400 */ transition: color 0.2s; }
        .tts-button:hover, .tts-button.playing { color: #7c3aed; /* purple-600 */ }
        
        /* Stili riassunto (prose) */
        .prose h3 {
            font-size: 1.5rem; /* text-2xl */
            font-weight: 600; /* font-semibold */
            color: #7e22ce; /* purple-700 */
            margin-top: 2rem; /* mt-8 */
            margin-bottom: 1rem; /* mb-4 */
            padding-bottom: 0.25rem; /* pb-1 */
            border-bottom: 1px solid #ddd6fe; /* purple-200 */
        }
        .prose p, .prose ul {
            font-size: 1rem;
            line-height: 1.75;
            color: #374151; /* gray-700 */
            margin-bottom: 1.25rem; /* mb-5 */
        }
        .prose strong {
            color: #5b21b6; /* purple-800 */
            font-weight: 600;
        }
        .prose ul {
            list-style-type: disc;
            padding-left: 1.75rem; /* pl-7 */
        }
        .prose li {
            margin-bottom: 0.5rem; /* mb-2 */
        }

        /* Quiz */
        .quiz-question { border: 1px solid #ddd6fe; /* purple-200 */ transition: all 0.3s; }
        .quiz-option:hover { background-color: #faf5ff; /* purple-50 */ }
        .quiz-question.correct { background-color: #dcfce7; border-color: #4ade80; } /* Verde per corretto */
        .quiz-question.incorrect { background-color: #fee2e2; border-color: #f87171; } /* Rosso per errato */

        /* Stili per h4 nel riassunto */
        .prose h4 {
            font-size: 1.25rem; /* text-xl */
            font-weight: 600; /* font-semibold */
            color: #7e22ce; /* purple-700 */
            margin-top: 1.5rem; /* mt-6 */
            margin-bottom: 0.75rem; /* mb-3 */
        }
        .dsa-mode .prose h4 {
            color: #1e293b; /* slate-800 */
        }

        /* Stili per la stampa */
        @media print {
            #main-header, #main-footer, #page-nav, #infografica, #quiz, #audio, #print-button, .tts-button, a[href*="infografica"], a[href*="index.info"] { display: none; }
            body, .content-section { background-color: #ffffff !important; color: #000000 !important; }
            .content-section { box-shadow: none; border: none; }
            h1, h2, h3, h4, p, li, strong { color: #000000 !important; }
            .prose h3 { border-color: #000000; }
        }
    </style>
</head>
<body class="bg-purple-50">

    <header id="main-header" class="bg-purple-800 text-white shadow-md sticky top-0 z-50">
        <nav class="container mx-auto px-6 py-3 flex justify-between items-center flex-wrap">
            <h1 class="text-xl font-bold !text-white !border-none !m-0 !p-0 !text-left" data-lang-key="siteTitle">Patologie Sistema Nervoso</h1>
            <div class="flex items-center space-x-4">
                <button id="accessibility-toggle" aria-label="Attiva modalit√† ad alta leggibilit√†" class="text-sm font-semibold px-3 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition" data-lang-key="accessibility">Accessibilit√†</button>
                <button id="lang-toggle" aria-label="Change language" class="text-sm font-semibold px-3 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition">EN</button>
            </div>
        </nav>
    </header>

    <main class="container mx-auto p-4 md:p-10">
        <div class="text-left mb-8">
            <!-- Corretto il link per puntare all'indice della neurologia -->
            <a href="index.info" class="inline-flex items-center bg-white text-purple-700 font-bold py-2 px-4 rounded-lg shadow hover:bg-purple-100 transition duration-300" data-lang-key="backToIndex">
                <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20"><path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm.707-10.293a1 1 0 00-1.414-1.414l-3 3a1 1 0 000 1.414l3 3a1 1 0 001.414-1.414L9.414 11H13a1 1 0 100-2H9.414l1.293-1.293z" clip-rule="evenodd"></path></svg>
                <span data-lang-key="backToIndexText">Indice Neurologia</span>
            </a>
        </div>
        
        <div class="content-section p-6 md:p-10">
            <header class="text-center border-b-2 border-purple-200 pb-6 mb-8">
                <h1 class="text-4xl md:text-5xl font-bold text-purple-800" data-lang-key="pageTitle">Epilessia Idiopatica (Cane)<span class="tts-button"><svg class="w-8 h-8" fill="currentColor" viewBox="0 0 20 20"><path d="M9.383 3.076A1 1 0 0110 4v12a1 1 0 01-1.707.707L4.586 13H2a1 1 0 01-1-1V8a1 1 0 011-1h2.586l3.707-3.707a1 1 0 011.09-.217zM14.657 2.929a1 1 0 011.414 0A9.972 9.972 0 0119 10a9.972 9.972 0 01-2.929 7.071 1 1 0 01-1.414-1.414A7.971 7.971 0 0017 10c0-2.21-.894-4.208-2.343-5.657a1 1 0 010-1.414zm-2.829 2.828a1 1 0 011.415 0A5.983 5.983 0 0115 10a5.984 5.984 0 01-1.757 4.243 1 1 0 01-1.415-1.415A3.984 3.984 0 0013 10a3.983 3.983 0 00-1.172-2.828 1 1 0 010-1.414z"/></svg></span></h1>
                <p class="text-lg text-purple-700 mt-2" data-lang-key="pageSubtitle">Diagnosi e gestione della pi√π comune causa di epilessia nel cane.</p>
            </header>

            <nav id="page-nav" class="flex justify-center flex-wrap gap-4 md:gap-8 mb-10 border-b border-gray-200">
                <a href="#riassunto" class="nav-link font-semibold py-2" data-lang-key="navSummary">Riassunto</a>
                <a href="#infografica" class="nav-link font-semibold py-2" data-lang-key="navInfographic">Infografica</a>
                <a href="#quiz" class="nav-link font-semibold py-2" data-lang-key="navQuiz">Quiz</a>
                <a href="#audio" class="nav-link font-semibold py-2" data-lang-key="navAudio">Audio</a>
                <a href="#bibliografia" class="nav-link font-semibold py-2" data-lang-key="navBibliography">Bibliografia</a>
            </nav>

            <article class="space-y-12">
                <section id="riassunto">
                    <h2 class="text-3xl font-bold text-purple-700 mb-4 flex items-center" data-lang-key="summaryTitle">Riassunto Completo <span class="tts-button"><svg class="w-7 h-7" fill="currentColor" viewBox="0 0 20 20"><path d="M9.383 3.076A1 1 0 0110 4v12a1 1 0 01-1.707.707L4.586 13H2a1 1 0 01-1-1V8a1 1 0 011-1h2.586l3.707-3.707a1 1 0 011.09-.217zM14.657 2.929a1 1 0 011.414 0A9.972 9.972 0 0119 10a9.972 9.972 0 01-2.929 7.071 1 1 0 01-1.414-1.414A7.971 7.971 0 0017 10c0-2.21-.894-4.208-2.343-5.657a1 1 0 010-1.414zm-2.829 2.828a1 1 0 011.415 0A5.983 5.983 0 0115 10a5.984 5.984 0 01-1.757 4.243 1 1 0 01-1.415-1.415A3.984 3.984 0 0013 10a3.983 3.983 0 00-1.172-2.828 1 1 0 010-1.414z"/></svg></span></h2>
                    <div class="prose max-w-none" data-lang-key="summaryContent">
                        
                        <h3 class="text-2xl font-semibold mt-6 mb-3">Definizione e Segnalamento</h3>
                        <p>L'<strong>Epilessia Idiopatica (EI)</strong> √® la pi√π comune causa di crisi convulsive ricorrenti nel cane. √à una diagnosi di esclusione: non c'√® una causa metabolica (crisi reattiva) n√© una lesione cerebrale visibile (epilessia strutturale).</p>
                        <p>Si basa su criteri specifici (definiti dall'International Veterinary Epilepsy Task Force - IVETF):</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Et√† d'insorgenza:</strong> Tipicamente tra <strong>6 mesi e 6 anni</strong>.</li>
                            <li><strong>Tipo di crisi:</strong> Spesso crisi generalizzate tonico-cloniche, ma possibili anche crisi focali.</li>
                            <li><strong>Esame neurologico:</strong> Strettamente <strong>normale</strong> nel periodo inter-ictale (tra una crisi e l'altra).</li>
                            <li><strong>Esami diagnostici:</strong> Esami del sangue (Tier 1), Risonanza Magnetica (Tier 2) e Analisi del LCR (Tier 3) devono essere tutti <strong>normali</strong>.</li>
                        </ul>
                        <p>√à riconosciuta una <strong>predisposizione genetica</strong> in molte razze, tra cui Labrador e Golden Retriever, Border Collie, Pastore Australiano, Beagle e molte altre.</p>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Diagnosi</h3>
                        <p>La diagnosi di EI si ottiene confermando la "normalit√†" del paziente al di fuori delle crisi, escludendo tutte le altre possibili cause (come discusso nella sezione "Approccio alle Crisi Convulsive"). La fiducia nella diagnosi aumenta con il numero di Tiers completati:</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Sospetto (Tier 1):</strong> Et√† compatibile, esame neurologico normale, esami ematici e urinari normali (che escludono cause reattive come ipoglicemia o shunt epatico).</li>
                            <li><strong>Conferma (Tier 2 & 3):</strong> Tier 1 normale + MRI encefalo normale + Analisi LCR normale.</li>
                        </ul>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Terapia Cronica</h3>
                        <p>L'EI √® una condizione che si gestisce, non si cura. L'obiettivo non √® eliminare il 100% delle crisi, ma trovare il miglior equilibrio tra riduzione della frequenza/gravit√† delle crisi e minimi effetti collaterali, per garantire una buona qualit√† di vita.</p>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">Quando iniziare la terapia?</h4>
                        <p>Non tutti i cani con EI necessitano di terapia immediata. L'inizio √® fortemente raccomandato se:</p>
                        <ul class="list-disc pl-6">
                            <li>L'animale ha presentato <strong>Stato Epilettico</strong> o <strong>Cluster Seizures</strong>.</li>
                            <li>La frequenza delle crisi √® <strong>> 1-2 crisi ogni 6 mesi</strong>.</li>
                            <li>La fase post-ictale √® particolarmente grave o prolungata.</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">Farmaci di Prima Scelta (Monoterapia)</h4>
                        <ul class="list-disc pl-6">
                            <li><strong>Fenobarbitale:</strong> Molto efficace ed economico. Richiede due somministrazioni/die (emivita 12h). Richiede 10-14 giorni per raggiungere lo steady-state. <strong>Contro:</strong> PU/PD/Polifagia, sedazione (spesso transitoria), potenziale epatotossicit√† (richiede monitoraggio periodico degli enzimi epatici e della funzionalit√† epatica).</li>
                            <li><strong>Imepitoina:</strong> Approvato specificamente per EI. Buona sicurezza, minori effetti sedativi e metabolici rispetto al Fenobarbitale. <strong>Contro:</strong> Meno efficace per crisi gravi (cluster/status), pi√π costoso.</li>
                            <li><strong>Potassio Bromuro (KBr):</strong> Spesso usato in combinazione (add-on) ma pu√≤ essere prima scelta. Emivita molto lunga (24 giorni). <strong>Contro:</strong> Richiede mesi per raggiungere lo steady-state (a meno di dose da carico), pu√≤ causare sedazione, atassia, e pancreatite. <strong>VIETATO NEL GATTO</strong> (causa polmonite allergica fatale).</li>
                        </ul>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">Terapia "Add-on" (Politerapia)</h4>
                        <p>Se un farmaco (a dosaggio terapeutico) non controlla le crisi (fallimento >50% riduzione frequenza), si aggiunge un secondo farmaco.</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Levetiracetam (KEPPRA):</strong> Ottimo profilo di sicurezza, non metabolizzato dal fegato. <strong>Contro:</strong> Emivita molto breve (richiede 3 somministrazioni/die - TID), costoso, possibile "effetto luna di miele" (perdita di efficacia nel tempo).</li>
                            <li><strong>Zonisamide:</strong> Buona efficacia, somministrazione 2 volte/die (BID). <strong>Contro:</strong> Possibili effetti collaterali (es. KCS, reazioni idiosincratiche).</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">Monitoraggio</h4>
                        <p>Il monitoraggio √® cruciale. Include il <strong>diario delle crisi</strong> (tenuto dal proprietario) e controlli veterinari con <strong>esami del sangue</strong>: controllo dei livelli sierici del farmaco (es. Fenobarbitalemia, Bromuremia) per assicurarsi che siano nel range terapeutico, e controllo della biochimica (soprattutto enzimi epatici per il Fenobarbitale).</p>
                    </div>
                </section>

                <section id="infografica">
                    <h2 class="text-3xl font-bold text-purple-700 mb-4" data-lang-key="infographicTitle">Infografica Riepilogativa</h2>
                        <a href="infografica_epilessia_idiopatica.html" target="_blank" class="block bg-white p-6 rounded-lg shadow-lg hover:shadow-xl transition-shadow border-l-4 border-purple-500">
                            <div class="flex items-center space-x-6">
                                <div class="flex-shrink-0 w-24 h-24 bg-purple-500 rounded-lg flex items-center justify-center">
                                    <!-- Icona Emoji Cane -->
                                    <span class="text-5xl" role="img" aria-label="Icona di un cane">üê∂</span>
                                </div>
                                <div>
                                    <h3 class="text-xl font-bold text-purple-800" data-lang-key="infographicLinkTitle">Visualizza la Gestione Terapeutica</h3>
                                    <p class="text-gray-600 mt-1" data-lang-key="infographicLinkDesc">Clicca per una guida visuale alla terapia cronica dell'Epilessia Idiopatica.</p>
                                </div>
                            </div>
                        </a>
                </section>

                <section id="quiz">
                    <h2 class="text-3xl font-bold text-purple-700 mb-4" data-lang-key="quizTitle">Quiz di Autovalutazione</h2>
                    <div id="quiz-container" class="space-y-6">
                        <!-- Questions loaded by JS -->
                    </div>
                    <div class="mt-6 text-center">
                        <button id="submit-quiz" class="bg-purple-600 text-white font-bold py-3 px-8 rounded-lg hover:bg-purple-700 transition" data-lang-key="quizSubmit">Verifica Risposte</button>
                    </div>
                    <div id="quiz-results" class="mt-6 text-center text-xl font-bold"></div>
                </section>

                <section id="audio">
                    <h2 class="text-3xl font-bold text-purple-700 mb-4" data-lang-key="audioTitle">Ascolta il Riassunto</h2>
                    <div class="p-4 bg-purple-100/50 rounded-lg flex flex-col sm:flex-row items-center gap-4 w-full">
                        <button id="audio-play-pause" class="p-3 bg-purple-500 text-white rounded-full hover:bg-purple-600 transition-colors duration-200">
                            <svg id="play-icon" xmlns="http://www.w3.org/2000/svg" class="h-8 w-8" viewBox="0 0 20 20" fill="currentColor">
                                <path d="M6.3 2.841A1.5 1.5 0 004 4.11v11.78a1.5 1.5 0 002.3 1.27l9.344-5.89a1.5 1.5 0 000-2.538L6.3 2.84z" />
                            </svg>
                            <svg id="pause-icon" xmlns="http://www.w3.org/2000/svg" class="h-8 w-8 hidden" viewBox="0 0 20 20" fill="currentColor">
                                <path d="M5.75 4.5a.75.75 0 00-.75.75v10a.75.75 0 001.5 0v-10a.75.75 0 00-.75-.75zM14.25 4.5a.75.75 0 00-.75.75v10a.75.75 0 001.5 0v-10a.75.75 0 00-.75-.75z" />
                            </svg>
                        </button>
                        <div class="flex-grow text-center sm:text-left">
                            <p class="font-semibold text-purple-800" data-lang-key="audioListen">Ascolta il riassunto completo</p>
                            <p class="text-sm text-purple-600" data-lang-key="audioDesc">Ideale per ripassare mentre sei in movimento.</p>
                        </div>
                        <a href="audio_epilessia_idiopatica.mp3" download class="bg-gray-500 text-white font-bold py-2 px-4 rounded-lg hover:bg-gray-600 transition inline-flex items-center w-full sm:w-auto justify-center">
                            <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20"><path fill-rule="evenodd" d="M3 17a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zm3.293-7.707a1 1 0 011.414 0L9 10.586V3a1 1 0 112 0v7.586l1.293-1.293a1 1 0 111.414 1.414l-3 3a1 1 0 01-1.414 0l-3-3a1 1 0 010-1.414z" clip-rule="evenodd" /></svg>
                            <span data-lang-key="btnDownloadAudio">Scarica</span>
                        </a>
                    </div>
                </section>

                <section id="bibliografia">
                    <h2 class="text-3xl font-bold text-purple-700 mb-4" data-lang-key="bibliographyTitle">Riferimenti Bibliografici</h2>
                    <ul class="list-disc pl-6 text-purple-900" data-lang-key="bibliographyContent">
                        <!-- Content loaded by JS -->
                    </ul>
                </section>
            </article>
            
            <div class="mt-12 text-center">
                <button id="print-button" onclick="window.print()" class="bg-gray-600 text-white font-bold py-2 px-6 rounded-lg hover:bg-gray-700 transition inline-flex items-center" data-lang-key="btnPrint">Stampa Riassunto</button>
            </div>
        </div>
    </main>
    <footer id="main-footer" class="text-center mt-16 pt-8 border-t border-purple-100">
        <p class="text-slate-500" data-lang-key="footer-credit">A cura della Prof.ssa Sara Busechian. Insegnamenti di clinica medica veterinaria</p>
    </footer>
    <script>
        document.addEventListener('DOMContentLoaded', () => {
            // --- TRADUZIONI ---
            const translations = {
                siteTitle: { it: "Patologie Sistema Nervoso", en: "Nervous System Diseases" },
                backToIndexText: { it: "Indice Neurologia", en: "Neurology Index" },
                pageTitle: { it: "Epilessia Idiopatica (Cane)", en: "Idiopathic Epilepsy (Dog)" },
                pageSubtitle: { it: "Diagnosi e gestione della pi√π comune causa di epilessia nel cane.", en: "Diagnosis and management of the most common cause of epilepsy in dogs." },
                navSummary: { it: "Riassunto", en: "Summary" },
                navInfographic: { it: "Infografica", en: "Infographic" },
                navQuiz: { it: "Quiz", en: "Quiz" },
                navAudio: { it: "Audio", en: "Audio" },
                navBibliography: { it: "Bibliografia", en: "Bibliography" },
                summaryTitle: { it: "Riassunto Completo", en: "Full Summary" },
                summaryContent: { 
                    it: `<h3 class="text-2xl font-semibold mt-6 mb-3">Definizione e Segnalamento</h3>
                        <p>L'<strong>Epilessia Idiopatica (EI)</strong> √® la pi√π comune causa di crisi convulsive ricorrenti nel cane. √à una diagnosi di esclusione: non c'√® una causa metabolica (crisi reattiva) n√© una lesione cerebrale visibile (epilessia strutturale).</p>
                        <p>Si basa su criteri specifici (definiti dall'International Veterinary Epilepsy Task Force - IVETF):</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Et√† d'insorgenza:</strong> Tipicamente tra <strong>6 mesi e 6 anni</strong>.</li>
                            <li><strong>Tipo di crisi:</strong> Spesso crisi generalizzate tonico-cloniche, ma possibili anche crisi focali.</li>
                            <li><strong>Esame neurologico:</strong> Strettamente <strong>normale</strong> nel periodo inter-ictale (tra una crisi e l'altra).</li>
                            <li><strong>Esami diagnostici:</strong> Esami del sangue (Tier 1), Risonanza Magnetica (Tier 2) e Analisi del LCR (Tier 3) devono essere tutti <strong>normali</strong>.</li>
                        </ul>
                        <p>√à riconosciuta una <strong>predisposizione genetica</strong> in molte razze, tra cui Labrador e Golden Retriever, Border Collie, Pastore Australiano, Beagle e molte altre.</p>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Diagnosi</h3>
                        <p>La diagnosi di EI si ottiene confermando la "normalit√†" del paziente al di fuori delle crisi, escludendo tutte le altre possibili cause (come discusso nella sezione "Approccio alle Crisi Convulsive"). La fiducia nella diagnosi aumenta con il numero di Tiers completati:</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Sospetto (Tier 1):</strong> Et√† compatibile, esame neurologico normale, esami ematici e urinari normali (che escludono cause reattive come ipoglicemia o shunt epatico).</li>
                            <li><strong>Conferma (Tier 2 & 3):</strong> Tier 1 normale + MRI encefalo normale + Analisi LCR normale.</li>
                        </ul>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Terapia Cronica</h3>
                        <p>L'EI √® una condizione che si gestisce, non si cura. L'obiettivo non √® eliminare il 100% delle crisi, ma trovare il miglior equilibrio tra riduzione della frequenza/gravit√† delle crisi e minimi effetti collaterali, per garantire una buona qualit√† di vita.</p>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">Quando iniziare la terapia?</h4>
                        <p>Non tutti i cani con EI necessitano di terapia immediata. L'inizio √® fortemente raccomandato se:</p>
                        <ul class="list-disc pl-6">
                            <li>L'animale ha presentato <strong>Stato Epilettico</strong> o <strong>Cluster Seizures</strong>.</li>
                            <li>La frequenza delle crisi √® <strong>> 1-2 crisi ogni 6 mesi</strong>.</li>
                            <li>La fase post-ictale √® particolarmente grave o prolungata.</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">Farmaci di Prima Scelta (Monoterapia)</h4>
                        <ul class="list-disc pl-6">
                            <li><strong>Fenobarbitale:</strong> Molto efficace ed economico. Richiede due somministrazioni/die (emivita 12h). Richiede 10-14 giorni per raggiungere lo steady-state. <strong>Contro:</strong> PU/PD/Polifagia, sedazione (spesso transitoria), potenziale epatotossicit√† (richiede monitoraggio periodico degli enzimi epatici e della funzionalit√† epatica).</li>
                            <li><strong>Imepitoina:</strong> Approvato specificamente per EI. Buona sicurezza, minori effetti sedativi e metabolici rispetto al Fenobarbitale. <strong>Contro:</strong> Meno efficace per crisi gravi (cluster/status), pi√π costoso.</li>
                            <li><strong>Potassio Bromuro (KBr):</strong> Spesso usato in combinazione (add-on) ma pu√≤ essere prima scelta. Emivita molto lunga (24 giorni). <strong>Contro:</strong> Richiede mesi per raggiungere lo steady-state (a meno di dose da carico), pu√≤ causare sedazione, atassia, e pancreatite. <strong>VIETATO NEL GATTO</strong> (causa polmonite allergica fatale).</li>
                        </ul>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">Terapia "Add-on" (Politerapia)</h4>
                        <p>Se un farmaco (a dosaggio terapeutico) non controlla le crisi (fallimento >50% riduzione frequenza), si aggiunge un secondo farmaco.</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Levetiracetam (KEPPRA):</strong> Ottimo profilo di sicurezza, non metabolizzato dal fegato. <strong>Contro:</strong> Emivita molto breve (richiede 3 somministrazioni/die - TID), costoso, possibile "effetto luna di miele" (perdita di efficacia nel tempo).</li>
                            <li><strong>Zonisamide:</strong> Buona efficacia, somministrazione 2 volte/die (BID). <strong>Contro:</strong> Possibili effetti collaterali (es. KCS, reazioni idiosincratiche).</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">Monitoraggio</h4>
                        <p>Il monitoraggio √® cruciale. Include il <strong>diario delle crisi</strong> (tenuto dal proprietario) e controlli veterinari con <strong>esami del sangue</strong>: controllo dei livelli sierici del farmaco (es. Fenobarbitalemia, Bromuremia) per assicurarsi che siano nel range terapeutico, e controllo della biochimica (soprattutto enzimi epatici per il Fenobarbitale).</p>`,
                    en: `<h3 class="text-2xl font-semibold mt-6 mb-3">Definition and Signalment</h3>
                        <p><strong>Idiopathic Epilepsy (IE)</strong> is the most common cause of recurrent seizures in dogs. It is a diagnosis of exclusion: there is no metabolic cause (reactive seizure) nor a visible brain lesion (structural epilepsy).</p>
                        <p>It is based on specific criteria (defined by the International Veterinary Epilepsy Task Force - IVETF):</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Age of Onset:</strong> Typically between <strong>6 months and 6 years</strong>.</li>
                            <li><strong>Seizure Type:</strong> Often generalized tonic-clonic seizures, but focal seizures are also possible.</li>
                            <li><strong>Neurological Exam:</strong> Strictly <strong>normal</strong> in the inter-ictal period (between seizures).</li>
                            <li><strong>Diagnostics:</strong> Blood tests (Tier 1), MRI (Tier 2), and CSF analysis (Tier 3) must all be <strong>normal</strong>.</li>
                        </ul>
                        <p>A <strong>genetic predisposition</strong> is recognized in many breeds, including Labrador and Golden Retrievers, Border Collies, Australian Shepherds, Beagles, and many others.</p>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Diagnosis</h3>
                        <p>The diagnosis of IE is made by confirming the patient's "normality" outside of seizures and ruling out all other possible causes (as discussed in the "Approach to Seizures" section). Confidence in the diagnosis increases with the Tiers completed:</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Suspicion (Tier 1):</strong> Compatible age, normal neurological exam, normal blood and urine tests (ruling out reactive causes like hypoglycemia or hepatic shunt).</li>
                            <li><strong>Confirmation (Tier 2 & 3):</strong> Tier 1 normal + normal brain MRI + normal CSF analysis.</li>
                        </ul>

                        <h3 class="text-2xl font-semibold mt-6 mb-3">Chronic Therapy</h3>
                        <p>IE is a condition to be managed, not cured. The goal is not to eliminate 100% of seizures, but to find the best balance between reducing seizure frequency/severity and minimizing side effects, ensuring a good quality of life.</p>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">When to Start Therapy?</h4>
                        <p>Not all dogs with IE require immediate therapy. Starting is strongly recommended if:</p>
                        <ul class="list-disc pl-6">
                            <li>The animal has experienced <strong>Status Epilepticus</strong> or <strong>Cluster Seizures</strong>.</li>
                            <li>Seizure frequency is <strong>> 1-2 seizures every 6 months</strong>.</li>
                            <li>The post-ictal phase is particularly severe or prolonged.</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">First-Choice Drugs (Monotherapy)</h4>
                        <ul class="list-disc pl-6">
                            <li><strong>Phenobarbital:</strong> Very effective and inexpensive. Requires two administrations/day (12h half-life). Takes 10-14 days to reach steady-state. <strong>Cons:</strong> PU/PD/Polyphagia, sedation (often transient), potential hepatotoxicity (requires periodic monitoring of liver enzymes and function).</li>
                            <li><strong>Imepitoin:</strong> Specifically approved for IE. Good safety, fewer sedative and metabolic effects than Phenobarbital. <strong>Cons:</strong> Less effective for severe seizures (clusters/status), more expensive.</li>
                            <li><strong>Potassium Bromide (KBr):</strong> Often used in combination (add-on) but can be first choice. Very long half-life (24 days). <strong>Cons:</strong> Takes months to reach steady-state (unless loaded), can cause sedation, ataxia, and pancreatitis. <strong>FORBIDDEN IN CATS</strong> (causes fatal allergic pneumonitis).</li>
                        </ul>
                        
                        <h4 class="text-xl font-semibold mt-4 mb-2">"Add-on" Therapy (Polytherapy)</h4>
                        <p>If one drug (at a therapeutic dosage) fails to control seizures (>50% reduction in frequency failure), a second drug is added.</p>
                        <ul class="list-disc pl-6">
                            <li><strong>Levetiracetam (KEPPRA):</strong> Excellent safety profile, not metabolized by the liver. <strong>Cons:</strong> Very short half-life (requires 3 administrations/day - TID), expensive, possible "honeymoon effect" (loss of efficacy over time).</li>
                            <li><strong>Zonisamide:</strong> Good efficacy, administered twice daily (BID). <strong>Cons:</strong> Possible side effects (e.g., KCS, idiosyncratic reactions).</li>
                        </ul>

                        <h4 class="text-xl font-semibold mt-4 mb-2">Monitoring</h4>
                        <p>Monitoring is crucial. It includes a <strong>seizure diary</strong> (kept by the owner) and veterinary check-ups with <strong>blood tests</strong>: checking serum drug levels (e.g., Phenobarbital, Bromide) to ensure they are in the therapeutic range, and checking biochemistry (especially liver enzymes for Phenobarbital).</p>`
                },
                infographicTitle: { it: "Infografica Riepilogativa", en: "Summary Infographic" },
                infographicLinkTitle: { it: "Visualizza la Gestione Terapeutica", en: "View Therapeutic Management" },
                infographicLinkDesc: { it: "Clicca per una guida visuale alla terapia cronica dell'Epilessia Idiopatica.", en: "Click for a visual guide to chronic therapy for Idiopathic Epilepsy." },
                quizTitle: { it: "Quiz di Autovalutazione", en: "Self-Assessment Quiz" },
                quizSubmit: { it: "Verifica Risposte", en: "Check Answers" },
                audioTitle: { it: "Ascolta il Riassunto", en: "Listen to the Summary" },
                btnDownloadAudio: { it: "Scarica", en: "Download" },
                audioListen: { it: "Ascolta il riassunto completo", en: "Listen to the full summary" },
                audioDesc: { it: "Ideale per ripassare mentre sei in movimento.", en: "Ideal for reviewing on the go." },
                bibliographyTitle: { it: "Riferimenti Bibliografici", en: "Bibliographical References" },
                bibliographyContent: { 
                    it: `<li>Berendt M, Farquhar RG, Mandigers PJJ, et al. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. <i>BMC Vet Res</i>. 2015;11:182.</li>
                         <li>Bhatti SFM, De Risio L, Mu√±ana K, et al. International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe. <i>BMC Vet Res</i>. 2015;11:176.</li>
                         <li>De Risio L, Platt S. Canine and Feline Epilepsy: Diagnosis and Management. 1st ed. CABI, 2014.</li>
                         <li>Ettinger SJ, Feldman EC, Cot√© E. Ettinger's Textbook of Veterinary Internal Medicine. 9th ed. Elsevier, 2024.</li>`,
                    en: `<li>Berendt M, Farquhar RG, Mandigers PJJ, et al. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. <i>BMC Vet Res</i>. 2015;11:182.</li>
                         <li>Bhatti SFM, De Risio L, Mu√±ana K, et al. International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe. <i>BMC Vet Res</i>. 2015;11:176.</li>
                         <li>De Risio L, Platt S. Canine and Feline Epilepsy: Diagnosis and Management. 1st ed. CABI, 2014.</li>
                         <li>Ettinger SJ, Feldman EC, Cot√© E. Ettinger's Textbook of Veterinary Internal Medicine. 9th ed. Elsevier, 2024.</li>`
                },
                btnPrint: { it: "Stampa Riassunto", en: "Print Summary" },
                accessibility: { it: "Accessibilit√†", en: "Accessibility" },
                "footer-credit": { it: "A cura della Prof.ssa Sara Busechian. Insegnamenti di clinica medica veterinaria", en: "Curated by Prof. Sara Busechian. Veterinary clinical medicine teachings" }
            };

            // --- QUIZ DATA ---
            const quizData = {
                it: [
                    { question: "Qual √® l'intervallo di et√† tipico per l'insorgenza dell'Epilessia Idiopatica?", options: ["Meno di 6 mesi", "6 mesi - 6 anni", "Sempre oltre i 7 anni", "Solo in cani anziani"], answer: "6 mesi - 6 anni" },
                    { question: "Cosa significa che l'Epilessia Idiopatica √® una diagnosi di 'esclusione'?", options: ["Che si esclude la terapia", "Che si escludono i cani di razza", "Che si devono escludere cause reattive e strutturali", "Che si fa solo con l'EEG"], answer: "Che si devono escludere cause reattive e strutturali" },
                    { question: "Quale farmaco di prima scelta richiede un monitoraggio attento per l'epatotossicit√†?", options: ["Levetiracetam", "Imepitoina", "Fenobarbitale", "Potassio Bromuro"], answer: "Fenobarbitale" },
                    { question: "Quale farmaco √® VIETATO per la terapia cronica nel gatto?", options: ["Fenobarbitale", "Potassio Bromuro", "Levetiracetam", "Zonisamide"], answer: "Potassio Bromuro" },
                    { question: "Quale farmaco ha un'emivita molto breve e richiede 3 somministrazioni al giorno (TID)?", options: ["Fenobarbitale", "Potassio Bromuro", "Imepitoina", "Levetiracetam"], answer: "Levetiracetam" },
                    { question: "Per una diagnosi di EI con confidenza 'Tier 3', cosa deve essere normale?", options: ["Solo esami del sangue", "Sangue, MRI e LCR", "Solo MRI", "Solo esame neurologico"], answer: "Sangue, MRI e LCR" },
                    { question: "L'obiettivo della terapia cronica per l'EI √®:", options: ["Eliminare il 100% delle crisi", "Curare la malattia genetica", "Ridurre frequenza e gravit√† bilanciando gli effetti collaterali", "Sospendere la terapia dopo 1 anno"], answer: "Ridurre frequenza e gravit√† bilanciando gli effetti collaterali" },
                    { question: "Quale farmaco impiega mesi per raggiungere lo 'steady-state' (livello stabile)?", options: ["Diazepam", "Potassio Bromuro", "Levetiracetam", "Fenobarbitale"], answer: "Potassio Bromuro" },
                    { question: "Quando √® fortemente indicato iniziare una terapia anticonvulsivante?", options: ["Dopo la prima crisi in assoluto", "Dopo uno 'Stato Epilettico' o 'Cluster'", "Se il cane ha 7 anni", "Se il proprietario √® preoccupato"], answer: "Dopo uno 'Stato Epilettico' o 'Cluster'" },
                    { question: "L'esame neurologico di un cane con Epilessia Idiopatica nel periodo inter-ictale √®:", options: ["Sempre anormale", "Normale", "Mostra deficit propriocettivi", "Mostra head tilt"], answer: "Normale" }
                ],
                en: [
                    { question: "What is the typical age range of onset for Idiopathic Epilepsy?", options: ["Less than 6 months", "6 months - 6 years", "Always over 7 years", "Only in senior dogs"], answer: "6 months - 6 years" },
                    { question: "What does it mean that Idiopathic Epilepsy is a diagnosis of 'exclusion'?", options: ["That therapy is excluded", "That purebred dogs are excluded", "That reactive and structural causes must be ruled out", "That it's diagnosed only with EEG"], answer: "That reactive and structural causes must be ruled out" },
                    { question: "Which first-line drug requires careful monitoring for hepatotoxicity?", options: ["Levetiracetam", "Imepitoin", "Phenobarbital", "Potassium Bromide"], answer: "Phenobarbital" },
                    { question: "Which drug is FORBIDDEN for chronic therapy in cats?", options: ["Phenobarbital", "Potassium Bromide", "Levetiracetam", "Zonisamide"], answer: "Potassium Bromide" },
                    { question: "Which drug has a very short half-life, requiring 3 administrations per day (TID)?", options: ["Phenobarbital", "Potassium Bromide", "Imepitoin", "Levetiracetam"], answer: "Levetiracetam" },
                    { question: "For a 'Tier 3' confidence diagnosis of IE, what must be normal?", options: ["Only blood tests", "Blood, MRI, and CSF", "Only MRI", "Only neurological exam"], answer: "Blood, MRI, and CSF" },
                    { question: "The goal of chronic therapy for IE is:", options: ["To eliminate 100% of seizures", "To cure the genetic disease", "To reduce frequency and severity while balancing side effects", "To stop therapy after 1 year"], answer: "To reduce frequency and severity while balancing side effects" },
                    { question: "Which drug takes months to reach 'steady-state'?", options: ["Diazepam", "Potassium Bromide", "Levetiracetam", "Phenobarbital"], answer: "Potassium Bromide" },
                    { question: "When is it strongly indicated to start anticonvulsant therapy?", options: ["After the very first seizure", "After 'Status Epilepticus' or 'Clusters'", "If the dog is 7 years old", "If the owner is worried"], answer: "After 'Status Epilepticus' or 'Clusters'" },
                    { question: "The neurological exam of a dog with Idiopathic Epilepsy in the inter-ictal period is:", options: ["Always abnormal", "Normal", "Shows proprioceptive deficits", "Shows a head tilt"], answer: "Normal" }
                ]
            };
            
            let currentLanguage = localStorage.getItem('language') || 'it';
            
            const synth = window.speechSynthesis;
            let currentUtterance = null;
            let activeTTSButton = null;

            function stopSpeech() {
                if (synth.speaking || synth.paused) {
                    synth.cancel();
                }
            }
            
            function speak(text, button) {
                if (activeTTSButton === button && currentUtterance) {
                    if (synth.paused) {
                        synth.resume();
                        button.classList.add('playing');
                    } else if (synth.speaking) {
                        synth.pause();
                        button.classList.remove('playing');
                    }
                    return; 
                }

                stopSpeech();
                
                if(activeTTSButton) {
                    activeTTSButton.classList.remove('playing');
                }

                currentUtterance = new SpeechSynthesisUtterance(text);
                currentUtterance.lang = currentLanguage === 'it' ? 'it-IT' : 'en-US';
                
                const cleanup = () => {
                    if (button) button.classList.remove('playing');
                    activeTTSButton = null;
                    currentUtterance = null;
                };

                currentUtterance.onend = cleanup;
                currentUtterance.onerror = (event) => {
                     if (event.error !== 'canceled' && event.error !== 'interrupted') {
                        console.error('An error occurred with speech synthesis:', event.error);
                    }
                    cleanup();
                };

                activeTTSButton = button;
                button.classList.add('playing');
                synth.speak(currentUtterance);
            }

            let sound = null;

            function initHowler() {
                if (sound) { // Se gi√† inizializzato, distruggilo prima di ricreare
                    sound.unload();
                }
                const audioFile = 'audio_epilessia_idiopatica.mp3'; // NOME FILE AUDIO
                sound = new Howl({
                    src: [audioFile],
                    html5: true, 
                    onplay: () => { playIcon.classList.add('hidden'); pauseIcon.classList.remove('hidden'); },
                    onpause: () => { playIcon.classList.remove('hidden'); pauseIcon.classList.add('hidden'); },
                    onend: () => { playIcon.classList.remove('hidden'); pauseIcon.classList.add('hidden'); },
                    onloaderror: (id, msg) => {
                        console.error("Error loading audio:", msg);
                        const audioDesc = document.querySelector('[data-lang-key="audioDesc"]');
                        if (audioDesc) audioDesc.textContent = currentLanguage === 'it' ? "File audio non trovato." : "Audio file not found.";
                    },
                    onplayerror: (id, msg) => {
                        console.error("Error playing audio:", msg);
                        const audioDesc = document.querySelector('[data-lang-key="audioDesc"]');
                        if (audioDesc) audioDesc.textContent = currentLanguage === 'it' ? "Impossibile riprodurre l'audio." : "Could not play audio.";
                    }
                });
            }

            const playPauseBtn = document.getElementById('audio-play-pause');
            const playIcon = document.getElementById('play-icon');
            const pauseIcon = document.getElementById('pause-icon');

            playPauseBtn.addEventListener('click', () => {
                if (!sound || sound.state() === 'unloaded') initHowler();
                
                if (sound.playing()) {
                    sound.pause();
                } else {
                    sound.play();
                }
            });

            function setupTTSListeners() {
                document.querySelectorAll('.tts-button').forEach(button => {
                    const newButton = button.cloneNode(true);
                    button.parentNode.replaceChild(newButton, button);
                    newButton.addEventListener('click', (e) => {
                        e.stopPropagation();
                        e.preventDefault();
                        
                        let textToRead = '';
                        const parentElement = newButton.parentElement;

                        if (parentElement.tagName === 'H1' && parentElement.dataset.langKey === 'pageTitle') {
                            const titleClone = parentElement.cloneNode(true);
                            titleClone.querySelector('.tts-button').remove();
                            textToRead = titleClone.textContent.trim();
                            const subtitle = parentElement.nextElementSibling;
                            if(subtitle && subtitle.dataset.langKey === 'pageSubtitle') {
                                textToRead += '. ' + subtitle.textContent.trim();
                            }
                        }
                        else if (parentElement.tagName === 'H2') {
                            const section = parentElement.closest('section');
                            const titleClone = parentElement.cloneNode(true);
                            titleClone.querySelector('.tts-button').remove();
                            textToRead = titleClone.textContent.trim();

                            if (section && section.id === 'riassunto') {
                                const content = section.querySelector('[data-lang-key="summaryContent"]');
                                if (content) {
                                    const contentClone = content.cloneNode(true);
                                    // Rimuove tag non testuali
                                    contentClone.querySelectorAll('div, img, figure').forEach(el => el.remove());
                                    // Sostituisce h3 e h4 con punti per pause
                                    contentClone.querySelectorAll('h3, h4').forEach(el => {
                                        el.textContent = '. ' + el.textContent.trim() + '. ';
                                    });
                                    textToRead += '. ' + contentClone.textContent.trim().replace(/\s\s+/g, ' ');
                                }
                            }
                        } 
                        else if (parentElement.tagName === 'H3') {
                            const questionTextNode = parentElement.querySelector('span:first-child');
                            if (questionTextNode) textToRead = questionTextNode.textContent.trim().replace(/^\d+\.\s*/, '');
                        }
                        else if (parentElement.closest('label')) {
                            const label = parentElement.closest('label');
                            const answerTextNode = label.querySelector('span:first-child');
                            if (answerTextNode) textToRead = answerTextNode.textContent.trim();
                        }
                        
                        if (textToRead) speak(textToRead, newButton);
                    });
                });
            }

            function loadQuiz(lang) {
                const quizContainer = document.getElementById('quiz-container');
                quizContainer.innerHTML = '';
                document.getElementById('quiz-results').innerHTML = ''; 
                quizData[lang].forEach((q, index) => {
                    const questionDiv = document.createElement('div');
                    questionDiv.className = 'quiz-question p-4 rounded-lg';
                    let optionsHtml = q.options.map(o => `
                        <li class="quiz-option p-2 rounded hover:bg-purple-50">
                            <label class="flex items-center justify-between w-full cursor-pointer">
                                <span class="flex-grow pr-4"><input type="radio" name="q${index}" value="${o}" class="mr-3 text-purple-600 focus:ring-purple-500">${o}</span>
                                <span class="tts-button flex-shrink-0"><svg class="w-5 h-5" fill="currentColor" viewBox="0 0 20 20"><path d="M9.383 3.076A1 1 0 0110 4v12a1 1 0 01-1.707.707L4.586 13H2a1 1 0 01-1-1V8a1 1 0 011-1h2.586l3.707-3.707a1 1 0 011.09-.217zM14.657 2.929a1 1 0 011.414 0A9.972 9.972 0 0119 10a9.972 9.972 0 01-2.929 7.071 1 1 0 01-1.414-1.414A7.971 7.971 0 0017 10c0-2.21-.894-4.208-2.343-5.657a1 1 0 010-1.414zm-2.829 2.828a1 1 0 011.415 0A5.983 5.983 0 0115 10a5.984 5.984 0 01-1.757 4.243 1 1 0 01-1.415-1.415A3.984 3.984 0 0013 10a3.983 3.983 0 00-1.172-2.828 1 1 0 010-1.414z"/></svg></span>
                            </label>
                        </li>`).join('');
                    questionDiv.innerHTML = `<h3 class="font-semibold mb-2 flex items-center justify-between"><span>${index + 1}. ${q.question}</span><span class="tts-button"><svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20"><path d="M9.383 3.076A1 1 0 0110 4v12a1 1 0 01-1.707.707L4.586 13H2a1 1 0 01-1-1V8a1 1 0 011-1h2.586l3.707-3.707a1 1 0 011.09-.217zM14.657 2.929a1 1 0 011.414 0A9.972 9.972 0 0119 10a9.972 9.972 0 01-2.929 7.071 1 1 0 01-1.414-1.414A7.971 7.971 0 0017 10c0-2.21-.894-4.208-2.343-5.657a1 1 0 010-1.414zm-2.829 2.828a1 1 0 011.415 0A5.983 5.983 0 0115 10a5.984 5.984 0 01-1.757 4.243 1 1 0 01-1.415-1.415A3.984 3.984 0 0013 10a3.983 3.983 0 00-1.172-2.828 1 1 0 010-1.414z"/></svg></span></h3><ul class="space-y-1">${optionsHtml}</ul>`;
                    quizContainer.appendChild(questionDiv);
                });
            }

            function updateLanguage(lang) {
                document.documentElement.lang = lang;
                document.getElementById('lang-toggle').textContent = lang === 'it' ? 'EN' : 'IT';
                document.querySelectorAll('[data-lang-key]').forEach(element => {
                    const key = element.dataset.langKey;
                    if (translations[key] && translations[key][lang]) {
                        if (key.includes('Content') || key === 'bibliographyContent') {
                            element.innerHTML = translations[key][lang];
                        } else {
                            // Salva il bottone TTS se esiste
                            const ttsButton = element.querySelector('.tts-button');
                            element.textContent = translations[key][lang];
                            // Riaiungi il bottone TTS
                            if(ttsButton) element.appendChild(ttsButton);
                        }
                    }
                });
                
                // Gestione sezione Audio
                const navAudio = document.querySelector('a[data-lang-key="navAudio"]');
                const sectionAudio = document.getElementById('audio');
                if (lang === 'en') {
                    if(navAudio) navAudio.style.display = 'none';
                    if(sectionAudio) sectionAudio.style.display = 'none';
                    if(sound && sound.playing()) sound.stop(); // Ferma l'audio se si cambia in EN
                } else {
                    if(navAudio) navAudio.style.display = 'block';
                    if(sectionAudio) sectionAudio.style.display = 'block';
                }

                // Aggiorna testo bottone accessibilit√†
                const dsaToggle = document.getElementById('accessibility-toggle');
                if (document.body.classList.contains('dsa-mode')) {
                    dsaToggle.textContent = lang === 'it' ? 'Vista Standard' : 'Standard View';
                } else {
                    dsaToggle.textContent = lang === 'it' ? 'Accessibilit√†' : 'Accessibility';
                }
                
                loadQuiz(lang);
                setupTTSListeners(); // Ricollega i listener dopo aver cambiato la lingua
            }
            
            // --- EVENT LISTENERS ---

            document.getElementById('lang-toggle').addEventListener('click', () => {
                currentLanguage = currentLanguage === 'it' ? 'en' : 'it';
                localStorage.setItem('language', currentLanguage);
                stopSpeech();
                updateLanguage(currentLanguage);
            });

            const dsaToggle = document.getElementById('accessibility-toggle');
            dsaToggle.addEventListener('click', () => {
                document.body.classList.toggle('dsa-mode');
                 if (document.body.classList.contains('dsa-mode')) {
                    dsaToggle.textContent = currentLanguage === 'it' ? 'Vista Standard' : 'Standard View';
                } else {
                    dsaToggle.textContent = currentLanguage === 'it' ? 'Accessibilit√†' : 'Accessibility';
                }
            });

            document.getElementById('submit-quiz').addEventListener('click', () => {
                let score = 0;
                const questions = document.querySelectorAll('.quiz-question');
                quizData[currentLanguage].forEach((q, index) => {
                    const selected = document.querySelector(`input[name="q${index}"]:checked`);
                    questions[index].classList.remove('correct', 'incorrect');
                    if (selected) {
                        if (selected.value === q.answer) {
                            score++;
                            questions[index].classList.add('correct');
                        } else {
                            questions[index].classList.add('incorrect');
                        }
                    } else {
                        questions[index].classList.add('incorrect');
                    }
                });
                const resultsContainer = document.getElementById('quiz-results');
                const resultText = {
                    it: `Hai risposto correttamente a ${score} su ${quizData.it.length} domande.`,
                    en: `You answered ${score} out of ${quizData.en.length} questions correctly.`
                };
                resultsContainer.textContent = resultText[currentLanguage];
            });
            
            // Initial setup
            updateLanguage(currentLanguage);
        });
    </script>
</body>
</html>
